Misconceptions about Alzheimer's varies among races, survey suggests

Alzheimer's disease is still a mystery to people of different races and a large percentage of people across the board are unaware that treatments are available to reduce symptoms.

This is one of the surprising findings in a national survey, "Public opinion about Alzheimer's disease among Blacks, Hispanics, and Whites," which was analyzed by researchers at the University of Michigan School of Public Health. Understanding racial and ethnic influences on knowledge and beliefs about Alzheimer's is critical to communicating risk reduction strategies, symptom recognition, diagnosis and illness management, the paper said.

There were more similarities in patterns of response among the racial groups than expected, said Cathleen Connell, professor in the U-M School of Public Health and director of the Education and Information Transfer Core of the Michigan Alzheimer's Disease Research Center. One half of the sample reported that nothing can be done to maintain cognitive functioning and reduce Alzheimer's risk. Similarly, less than half of the sample was aware that treatments can address symptoms and improve quality of life. There were no significant differences among races in the level of concern about getting Alzheimer's disease.

However, some notable differences among blacks, whites and Hispanics were discovered, Connell said. Many more blacks and Hispanics than whites responded that they believe that Alzheimer's is a normal part of aging.

"If family members believe that Alzheimer's disease is the term for normal memory loss associated with aging, they will be less likely to seek diagnosis and treatment in the early phase of the process when more options are available," Connell said. "To the extent that non-whites are much more likely than whites to normalize symptoms of dementia, we need to do a much better job of tailoring messages in an effort to increase public awareness about the disease."

Blacks and Hispanics were much more hopeful than whites about research advances toward a cure, which may reflect a hopeful outlook "related to spirituality and religiosity, both of which play a significant role in health decision making," the paper said. In keeping with this higher level of optimism, blacks and Hispanics were more likely to report changing their diet or lifestyle to avoid developing Alzheimer's disease than whites.

Hispanics reported feeling more well-prepared for handling a diagnosis of Alzheimer's in the family than blacks or whites. But overall, only one fourth of respondents reported feeling prepared for such a diagnosis in the family.

Researchers gave 1,776 black, Hispanic and white adults brief phone interviews to assess their levels of knowledge and beliefs about the disease; their concern about getting other prevalent chronic diseases; and whether they reported any lifestyle changes to reduce the risk of disease.

"Although knowledge about Alzheimer's disease has increased dramatically over the past two decades, misconceptions remain among large segments of the population," Connell said. "Continued efforts are clearly needed to educate the public about the disease."

Further studies are needed to better interpret the survey findings, but they will likely need to be in-depth qualitative studies. However, a large percentage of the overall sample responded in ways that suggested a need for more outreach and education, independent of race.

Connell is associate director for the Center for Managing Chronic Disease, and lead author of the study, which appears in the September issue of the journal Alzheimer Disease and Associated Disorders. Co-authors include J. Scott Roberts, assistant professor in the School of Public Health, and Sara McLaughlin, doctoral candidate in the School of Public Health.

Source: University of Michigan

Related stories:

Protecting patient privacy the new fashioned way
Protecting patient privacy has been recognized as the duty of health-care providers for about as long as doctors have seen patients. In 1996 that duty became a legal obligation when Congress passed the Health Insurance Portability and Accountability Act.
Ibuprofen, aspirin, naproxen may be equally effective at reducing risk of Alzheimer's disease
Different types of non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, naproxen, and aspirin, appear to be equally effective in lowering the risk of Alzheimer’s disease, according to the largest study of its kind published in the May 28, 2008, online issue of Neurology, the medical journal of the American Academy of Neurology. Experts have debated whether a certain group of NSAIDs that includes ibuprofen may be more beneficial than another group that includes naproxen and aspirin.
Researchers explore the emerging role of infection in Alzheimer's disease
The realization that pathogens can produce slowly progressive chronic diseases has opened new lines of research into Alzheimer's disease. In a special issue of the Journal of Alzheimer's Disease published May 2008, guest editors Judith Miklossy, from the University of British Columbia, and Ralph N. Martins, from Edith Cowan University and Hollywood Private Hospital, Perth, Western Australia, and a group of experts explore this exciting topic.
Obesity can increase dementia risk by up to 80 percent
Being obese can increase the risk of Alzheimer’s Disease by as much as 80 per cent, according to a study in the May issue of Obesity Reviews.
Risk of death from rofecoxib in some trials may have been misrepresented by study sponsor
A comparison of internal company documents, data submitted by the company to the FDA, and published clinical trial results indicates that the risk-benefit profile of rofecoxib in clinical trials involving patients with cognitive impairment may have been misrepresented by study sponsor Merck, according to an article in the April 16 issue of JAMA.
Diabetes in mid-life linked to increased risk of Alzheimer's disease
Men who develop diabetes in mid-life appear to significantly increase their risk of developing Alzheimer’s disease, according to a long-term study published in the April 9, 2008, online issue of Neurology, the medical journal of the American Academy of Neurology.
Salivary diagnostics, the 'magic mirror' to your health ... at your personal computer
Accuracy, convenience, and non-invasiveness are the most critical characteristics for any diagnostic tool. A new concept, Salivaomics Knowledge Base (SKB), an in silico (i.e., performed on computer or via computer simulation) saliva diagnostic atlas, is launching today during the 37th Annual Meeting of the American Association for Dental Research in Dallas, Texas.
Stem cell breakthrough offers diabetes hope
Scientists have discovered a new technique for turning embryonic stem cells into insulin-producing pancreatic tissue in what could prove a significant breakthrough in the quest to find new treatments for diabetes.

News discussion:

Medicine & Health news